A proton therapy model using discrete difference equations with an example of treating hepatocellular carcinoma

Proton therapy is a type of radiation therapy used to treat cancer. It provides more localized particle exposure than other types of radiotherapy (e.g., x-ray and electron) thus reducing damage to tissue surrounding a tumor and reducing unwanted side effects. We have developed a novel discrete diffe...

Full description

Saved in:
Bibliographic Details
Main Authors: Erin N. Bodine, K. Lars Monia
Format: Article
Language:English
Published: AIMS Press 2017-07-01
Series:Mathematical Biosciences and Engineering
Subjects:
Online Access:https://www.aimspress.com/article/doi/10.3934/mbe.2017047
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590036439138304
author Erin N. Bodine
K. Lars Monia
author_facet Erin N. Bodine
K. Lars Monia
author_sort Erin N. Bodine
collection DOAJ
description Proton therapy is a type of radiation therapy used to treat cancer. It provides more localized particle exposure than other types of radiotherapy (e.g., x-ray and electron) thus reducing damage to tissue surrounding a tumor and reducing unwanted side effects. We have developed a novel discrete difference equation model of the spatial and temporal dynamics of cancer and healthy cells before, during, and after the application of a proton therapy treatment course. Specifically, the model simulates the growth and diffusion of the cancer and healthy cells in and surrounding a tumor over one spatial dimension (tissue depth) and the treatment of the tumor with discrete bursts of proton radiation. We demonstrate how to use data from in vitro and clinical studies to parameterize the model. Specifically, we use data from studies of Hepatocellular carcinoma, a common form of liver cancer. Using the parameterized model we compare the ability of different clinically used treatment courses to control the tumor. Our results show that treatment courses which use conformal proton therapy (targeting the tumor from multiple angles) provides better control of the tumor while using lower treatment doses than a non-conformal treatment course, and thus should be recommend for use when feasible.
format Article
id doaj-art-341836894a1d4f8695b933646c0e5928
institution Kabale University
issn 1551-0018
language English
publishDate 2017-07-01
publisher AIMS Press
record_format Article
series Mathematical Biosciences and Engineering
spelling doaj-art-341836894a1d4f8695b933646c0e59282025-01-24T02:39:54ZengAIMS PressMathematical Biosciences and Engineering1551-00182017-07-0114488189910.3934/mbe.2017047A proton therapy model using discrete difference equations with an example of treating hepatocellular carcinomaErin N. Bodine0K. Lars Monia1Rhodes College, Department of Mathematics & Computer Science, 2000 N. Parkway, Memphis, TN 38112, USARhodes College, Department of Mathematics & Computer Science, 2000 N. Parkway, Memphis, TN 38112, USAProton therapy is a type of radiation therapy used to treat cancer. It provides more localized particle exposure than other types of radiotherapy (e.g., x-ray and electron) thus reducing damage to tissue surrounding a tumor and reducing unwanted side effects. We have developed a novel discrete difference equation model of the spatial and temporal dynamics of cancer and healthy cells before, during, and after the application of a proton therapy treatment course. Specifically, the model simulates the growth and diffusion of the cancer and healthy cells in and surrounding a tumor over one spatial dimension (tissue depth) and the treatment of the tumor with discrete bursts of proton radiation. We demonstrate how to use data from in vitro and clinical studies to parameterize the model. Specifically, we use data from studies of Hepatocellular carcinoma, a common form of liver cancer. Using the parameterized model we compare the ability of different clinically used treatment courses to control the tumor. Our results show that treatment courses which use conformal proton therapy (targeting the tumor from multiple angles) provides better control of the tumor while using lower treatment doses than a non-conformal treatment course, and thus should be recommend for use when feasible.https://www.aimspress.com/article/doi/10.3934/mbe.2017047cancer modelingproton therapydiscrete difference equationsdiffusionbragg peakbethe-bloch equationhepatocellular carcinoma
spellingShingle Erin N. Bodine
K. Lars Monia
A proton therapy model using discrete difference equations with an example of treating hepatocellular carcinoma
Mathematical Biosciences and Engineering
cancer modeling
proton therapy
discrete difference equations
diffusion
bragg peak
bethe-bloch equation
hepatocellular carcinoma
title A proton therapy model using discrete difference equations with an example of treating hepatocellular carcinoma
title_full A proton therapy model using discrete difference equations with an example of treating hepatocellular carcinoma
title_fullStr A proton therapy model using discrete difference equations with an example of treating hepatocellular carcinoma
title_full_unstemmed A proton therapy model using discrete difference equations with an example of treating hepatocellular carcinoma
title_short A proton therapy model using discrete difference equations with an example of treating hepatocellular carcinoma
title_sort proton therapy model using discrete difference equations with an example of treating hepatocellular carcinoma
topic cancer modeling
proton therapy
discrete difference equations
diffusion
bragg peak
bethe-bloch equation
hepatocellular carcinoma
url https://www.aimspress.com/article/doi/10.3934/mbe.2017047
work_keys_str_mv AT erinnbodine aprotontherapymodelusingdiscretedifferenceequationswithanexampleoftreatinghepatocellularcarcinoma
AT klarsmonia aprotontherapymodelusingdiscretedifferenceequationswithanexampleoftreatinghepatocellularcarcinoma
AT erinnbodine protontherapymodelusingdiscretedifferenceequationswithanexampleoftreatinghepatocellularcarcinoma
AT klarsmonia protontherapymodelusingdiscretedifferenceequationswithanexampleoftreatinghepatocellularcarcinoma